|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Agilent Technologies Inc., of Palo Alto, Calif., entered an agreement with IBM Corp., of Armonk, N.Y., to develop an informatics system designed to aid in drug discovery and development. The companies will collaborate to make IBM's DiscoveryLink data integration technology compatible with Agilent's Synapsia Informatics Workbench software family. Financial terms were not disclosed.
Aphton Corp., of Miami, said it filed with the FDA an application for fast-track designation for its antigastrin immunogen, G17DT, to treat gastric cancer. Aphton is conducting one Phase III and three Phase II trials for its antigastrin targeted therapy, which induces antibodies in ...